Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
b013
Triple-Negative Breast Carcinoma
Shanghai Jiaolian Drug Research and Development Co., Ltd
P2/3
CCC
(55)
Baricitinib
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2/3
CCC
(55)
Bedamustine
Classic Hodgkin Lymphoma
Children's Cancer Group, China
P2/3
CCC
(55)
Bortezomib
T-Lymphoblastic Lymphoma
Children's Oncology Group
P2/3
CCC
(55)
Capmatinib
Neoplasm
Cancer Research UK
P2/3
CCC
(55)
cb03-154
Amyotrophic Lateral Sclerosis
Shanghai Zhimeng Biopharma, Inc.
P2/3
CCC
(55)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology Group
P2/3
CCC
(55)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
T-Lymphoblastic Lymphoma
Children's Oncology Group
P2/3
CCC
(55)
Cobimetinib
Plasma Cell Myeloma
Cancer Research UK
P2/3
CCC
(55)
Dabigatran
Portal Vein Thrombosis
Institute of Liver and Biliary Sciences, India
P2/3
CCC
(55)
Dapagliflozin
Acute Coronary Syndrome
University of Sao Paulo
P2/3
CCC
(55)
DARATUMUMAB
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology Group
P2/3
CCC
(55)
dn022150+ag (stage ii)
Exocrine Pancreatic Carcinoma
Jiangxi Kvvit Pharmaceutical Co., Ltd.
P2/3
CCC
(55)
Eftilagimod Alfa
Breast Carcinoma
Immutep S.A.S.
P2/3
CCC
(55)
Elranatamab
Plasmablastic Lymphoma
University of Illinois at Chicago
P2/3
CCC
(55)
ETOPOSIDE
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2/3
CCC
(55)
Famotidine
Breast Cancer
Noha Mansour
P2/3
CCC
(55)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Obesity Disorder
Cedars-Sinai Medical Center
P2/3
CCC
(55)
Fosigotifator sodium tromethamine
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD
P2/3
CCC
(55)
Galantamine Hydrobromide
Spinal Cord Injury
Northwell Health
P2/3
CCC
(55)
Galunisertib
Amyotrophic Lateral Sclerosis
Gipfel Life Sciences GmbH
P2/3
CCC
(55)
Glenzocimab
Stroke Disorder
Assistance Publique - Hôpitaux de Paris
P2/3
CCC
(55)
Gnrh
Early-Onset Autosomal Dominant Alzheimer Disease
Nelly Pitteloud
P2/3
CCC
(55)
Gonadotropin-Releasing Hormone
Early-Onset Autosomal Dominant Alzheimer Disease
Nelly Pitteloud
P2/3
CCC
(55)
Hydrocortisone
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology Group
P2/3
CCC
(55)
Showing 726 to 750 of 1,055 assets
Previous
Page 30 of 43
Next